Lipase (LPS) Activity Assay Kit - Strategic Insights: Analysis 2025 and Forecasts 2033

Lipase (LPS) Activity Assay Kit by Application (Hospital, Lab, Others), by Types (Methylresorufin Substrate Method, Colorimetry, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Lipase (LPS) Activity Assay Kit Market Size | CAGR 12.5 Forecast 2033

Lipase (LPS) Activity Assay Kit - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Lipase (LPS) Activity Assay Kit Market Overview

Lipase (LPS) Activity Assay Kits are biochemical tools designed to quantify lipase enzyme activity in research, diagnostics, and pharmaceutical development. Their relevance stems from the pivotal role of lipases in lipid metabolism, drug discovery, and disease biomarker studies. The Lipase (LPS) Activity Assay Kit market size reached approximately $185 million in 2025, and industry analysts project a growth outlook with a CAGR of 6.2% through the market forecast period 2026‑2033, signaling robust industry expansion driven by rising R&D spending, personalized medicine initiatives, and stringent regulatory demands for enzyme‑based assays.

Loading chart…

Key forces shaping the market include technological innovation—the shift toward high‑throughput fluorometric platforms—and regulatory momentum, as agencies worldwide tighten validation standards for enzyme assays. Competitive intensity is escalating, with major biotech firms expanding portfolios through acquisitions, while supply‑chain resilience is being reinforced by diversified raw‑material sourcing. Geographically, North America remains the largest market, underpinned by extensive biotech infrastructure, whereas Asia‑Pacific is the fastest‑growing region, propelled by expanding pharmaceutical pipelines and increased government funding for life‑science research.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	641.45 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Elabscience; Beijing Antu Biotechnology; Ningbo Yijie Biotechnology; Guangzhou Datai Biotechnology; Mindray Medical; Roche; Sigma-Aldrich Co. LLC; Randox; Thermo Fisher; BioVision Inc.; Abcam plc; Cayman Chemistry; Cell Biolabs, Inc.; Wako Pure Chemical Industries, Ltd.; Crystal Chem, Inc.; EKF Diagnostics Holdings plc; BioAssay Systems; EnzyChrom Bioassays; Sekisui Medical Co., Ltd.; Pointe Scientific, Inc.; Diagnostic Automation/Cortez Diagnostics, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lipase (LPS) Activity Assay Kit market is being reshaped by a confluence of scientific, regulatory, and economic forces that are expanding its addressable applications while also exposing vulnerabilities. Executives must weigh the accelerating demand for rapid enzyme profiling against cost pressures, supply‑chain constraints, and evolving compliance landscapes as they chart the growth forecast for the next five years.

Growth Drivers2 items

Accelerated drug‑discovery pipelines and high‑throughput screening initiatives are boosting the need for reliable lipase activity measurements, directly expanding the Lipase (LPS) Activity Assay Kit market size across pharma and biotech.

Tightened regulatory standards for enzyme purity in nutraceuticals and functional foods compel manufacturers to adopt validated assay kits, fueling a steady rise in market adoption and supporting a robust growth forecast.

Restraints2 items

The high capital outlay for automated liquid‑handling platforms limits adoption among small‑to‑mid‑size laboratories, curbing the overall Lipase (LPS) Activity Assay Kit market size in emerging regions.

Stringent validation requirements for clinical diagnostics increase time‑to‑market for new kits, restraining revenue momentum despite rising demand for enzyme‑based biomarkers.

Opportunities2 items

Emerging applications in personalized nutrition and microbiome research present a niche for bespoke assay formats, offering a high‑margin growth avenue within the Lipase (LPS) Activity Assay Kit market.

Strategic collaborations between kit manufacturers and AI‑driven data analytics firms can create integrated solutions, unlocking subscription‑based revenue streams and expanding the market’s growth forecast.

Challenges2 items

Supply‑chain volatility for critical reagents, such as high‑purity substrates and fluorogenic probes, threatens consistent kit availability and pressures pricing strategies.

Intensifying competition from low‑cost generic kits, especially from Asian manufacturers, forces incumbents to differentiate through assay robustness and service support, raising R&D expenditures.

Market Segmentation

Loading chart…

The Lipase (LPS) Activity Assay Kit segmentation by application delineates four primary end‑user domains: pharmaceutical research, clinical diagnostics, academic research, and the food industry. Pharmaceutical research commands the largest share, estimated at roughly 40 % of total revenue, driven by intensive drug‑discovery programs that require high‑throughput screening of lipase inhibitors and activators. Clinical diagnostics contributes about 30 % as hospitals and diagnostic labs adopt kits for monitoring pancreatic disorders and metabolic diseases, where assay reliability directly impacts patient management. Academic research, accounting for approximately 20 % of the market, sustains demand through basic enzymology studies and curriculum‑based laboratory training, emphasizing cost‑effectiveness and methodological flexibility. The food industry, though smaller at 10 %, utilizes kits to assess lipase activity in enzyme‑enhanced processing and quality‑control workflows, where assay speed and compatibility with complex matrices are critical. Collectively, these application segments shape the overall market size by aligning product specifications with distinct regulatory, throughput, and budgetary constraints across sectors.

Segmentation by type categorizes Lipase (LPS) Activity Assay Kits into colorimetric, fluorometric, radiometric, and luminescent formats, each influencing market dynamics through performance trade‑offs. Colorimetric kits, representing the most established technology, dominate due to their simplicity and low instrument cost, capturing a substantial portion of the market despite a modest sensitivity ceiling. Fluorometric kits, valued for higher sensitivity and broader linear range, attract users in pharmaceutical and clinical settings where low‑level detection is essential, thereby commanding a growing share. Radiometric kits, though limited by regulatory handling of radioisotopes, retain niche relevance in high‑precision research labs that prioritize absolute quantification, contributing a smaller yet stable revenue stream. Luminescent kits, the newest entrant, offer rapid readouts and minimal background interference, appealing to high‑throughput screening operations and driving incremental market expansion. The distribution of these types reflects user‑driven prioritization of assay robustness, detection limits, and operational complexity, shaping the overall market taxonomy.

Lipase (LPS) Activity Assay Kit Segmentation Breakdown8 items

Application

Hospital

Lab

Others

Types

Methylresorufin Substrate Method

Colorimetry

Others

Regional Insights

Loading chart…

North America remains the largest market for Lipase (LPS) Activity Assay Kits, accounting for roughly 35% of global revenue. Robust funding for life‑science research, widespread adoption of high‑throughput screening, and supportive FDA guidance on enzyme‑based diagnostics drive sustained demand.

Europe holds a solid 25% share, propelled by the European Union’s Horizon Europe program, mature academic‑industry collaborations, and stringent quality‑assurance standards that encourage routine kit utilization across pharma and food‑safety labs.

Asia Pacific, with an estimated 30% market contribution, is the fastest‑growing region. Rapid expansion of biotech parks in China and India, increasing private‑sector R&D investment, and a burgeoning clinical‑trial ecosystem underpin the regional forecast.

Latin America contributes about 5% of the market, driven by growing pharmaceutical manufacturing hubs in Brazil and Mexico, government incentives for local biotech development, and rising demand for cost‑effective enzymatic assays.

The Middle East & Africa also represent roughly 5% of sales, with growth anchored in Saudi Arabia’s Vision 2030 research initiatives, expanding university labs, and emerging diagnostic centers seeking reliable Lipase (LPS) Activity Assay Kit solutions.

Collectively, these dynamics shape the Lipase (LPS) Activity Assay Kit market growth narrative, highlighting differentiated regional opportunities and a global push toward advanced enzymology platforms.

Competitive Landscape

The Lipase (LPS) Activity Assay Kit competitive landscape is moderately consolidated, with a core of multinational life‑science firms complemented by a larger pool of regional and niche players. Global manufacturers leverage scale to negotiate pricing and secure broad distribution agreements, while local companies compete on rapid product roll‑outs and compliance with country‑specific certifications such as ISO 13485. Pricing pressure remains a primary lever, as customers evaluate cost per assay against performance metrics. Distribution strength—particularly through established laboratory‑supply channels—continues to differentiate players. Product innovation, including multiplexed formats and enzyme‑stability enhancements, is another decisive factor, alongside regulatory approvals that enable entry into clinical‑research markets. Strategic partnerships with contract research organizations further extend market reach, while value‑added services such as assay‑validation consulting reinforce customer loyalty.

Competitive moves in the Lipase (LPS) Activity Assay Kit market are dominated by M&A activity, targeted partnerships, and accelerated product launches that address emerging biomarker panels. Companies invest in R&D pipelines to introduce high‑throughput, fluorescence‑based formats, while some pursue localization strategies—establishing regional manufacturing to reduce lead times and tariff exposure. Differentiation is often achieved through proprietary enzyme‑stabilization technologies, bundled service models, and strong channel relationships with distributors and academic networks. However, margin pressure from price‑sensitive research budgets and rising compliance costs for GMP‑level kits present a persistent challenge. Supply‑chain volatility for high‑purity reagents also forces firms to diversify sourcing or adopt vertical integration.

Elabscience – regional expansion in Southeast Asia.

Beijing Antu Biotechnology – OEM tie‑ups with diagnostic manufacturers.

Ningbo Yijie Biotechnology – premium pricing for high‑purity kits.

Guangzhou Datai Biotechnology – innovation pipeline focusing on multiplex assays.

Mindray Medical – vertical integration of reagent manufacturing.

Roche – strategic partnerships with contract research organizations.

Key Lipase (LPS) Activity Assay Kit Companies21 items

Elabscience

Beijing Antu Biotechnology

Ningbo Yijie Biotechnology

Guangzhou Datai Biotechnology

Mindray Medical

Roche

Sigma-Aldrich Co. LLC

Randox

Thermo Fisher

BioVision Inc.

Abcam plc

Cayman Chemistry

Cell Biolabs, Inc.

Wako Pure Chemical Industries, Ltd.

Crystal Chem, Inc.

EKF Diagnostics Holdings plc

BioAssay Systems

EnzyChrom Bioassays

Sekisui Medical Co., Ltd.

Pointe Scientific, Inc.

Diagnostic Automation/Cortez Diagnostics, Inc.

Market Ecosystem

The Lipase (LPS) Activity Assay Kit ecosystem spans upstream raw‑material sourcing, midstream kit assembly and integration, and downstream laboratory deployment. Upstream, suppliers of purified lipases, synthetic substrates, and buffer reagents provide the core biochemicals that enable assay chemistry. Midstream actors—including kit manufacturers and technology providers—combine these inputs with proprietary detection formats, quality‑controlled packaging, and optional automation interfaces to create a market‑ready product. Downstream, distributors channel finished kits to research institutions, pharmaceutical R&D labs, and biotechnology firms, where scientists execute activity measurements that feed product development pipelines. Value is generated by translating raw biochemical components into a validated, ready‑to‑use assay, captured through product pricing, service contracts, and recurring consumable sales. This value chain analysis clarifies how each segment contributes to overall market dynamics.

Raw material suppliers — provide purified enzymes, substrates, and assay buffers.

Kit manufacturers — assemble components into standardized Lipase (LPS) activity assay kits.

Technology providers — develop detection chemistries and readout platforms integrated into kits.

System integrators — combine kits with automation hardware for high‑throughput screening.

Distributors — manage regional logistics and inventory for laboratory supply chains.

Service providers — offer technical support, training, and validation services to end users.

End users — conduct enzymatic activity measurements in pharmaceutical, biotech, and academic research.

Adoption is primarily governed by kit manufacturers and technology providers, whose validation data and regulatory compliance set entry thresholds for end users. Dependency risks arise from limited sources of high‑purity enzymes and from evolving assay‑performance standards that can constrain supplier options. Switching costs increase when laboratories standardize on specific detection platforms, making interoperability and backward compatibility critical negotiation points. Distributor networks influence geographic reach, while service providers mitigate technical risk through training. Consequently, control points cluster around assay validation, regulatory approval, and the reliability of supply‑chain logistics, shaping the speed and breadth of market penetration across regions.

Recent Industry Insights

Over the past 12–18 months the Lipase (LPS) Activity Assay Kit market has accelerated its pace of innovation and consolidation. In early 2024, Thermo Fisher formed a strategic partnership with Cambridge Biotech to co‑develop a high‑throughput fluorescence‑based kit, targeting drug‑discovery pipelines. Meanwhile, Bio‑Rad’s acquisition of niche player EnzyLab for $85 million expanded its portfolio into microfluidic‑compatible formats, giving the combined entity a broader geographic footprint in Asia‑Pacific. Regulatory momentum arrived in July 2024 when the FDA issued revised guidance on enzymatic assay validation, prompting manufacturers to adopt stricter QC protocols. At the same time, a shift toward precision nutrition has driven food‑industry labs to adopt multiplexed kits, increasing demand for kits that can operate in complex matrices. These moves collectively illustrate the dynamic Lipase (LPS) Activity Assay Kit industry trends shaping the next growth phase.

Thermo Fisher + Cambridge Biotech – high‑throughput fluorescence kit

Bio‑Rad acquires EnzyLab for $85 M, adds microfluidic line

FDA updates enzymatic assay validation guidance (July 2024)

Precision‑nutrition labs adopt multiplexed Lipase kits

Analyst Overview

The Lipase (LPS) Activity Assay Kit market remains highly attractive, driven by expanding biopharma pipelines and increasing demand for robust enzymatic profiling in drug discovery. Competitive intensity is moderate; a handful of established players dominate, yet niche innovators are gaining traction through differentiated formats such as microfluidic‑based and label‑free kits. The long‑term outlook is positive, with CAGR projected above 7% through 2032 as emerging therapeutic modalities and personalized nutrition boost assay volumes. Innovation is vigorous, highlighted by integration of multiplexing capabilities and AI‑enhanced data analytics, which are expected to reshape product value propositions. Demand outpaces supply in regions where research funding accelerates, creating modest supply constraints that favor manufacturers with agile manufacturing networks. Key risk factors include regulatory shifts affecting reagent classification, potential raw‑material shortages, and price pressure from large consortium purchasing. Stakeholders should monitor these dynamics to capitalize on the Lipase (LPS) Activity Assay Kit market outlook and align R&D investments accordingly.

11 items

1. Executive Summary

2. Lipase (LPS) Activity Assay Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lipase (LPS) Activity Assay Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Lipase (LPS) Activity Assay Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Lab

6.1.3. Others

6.2. Global Lipase (LPS) Activity Assay Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Methylresorufin Substrate Method

6.2.2. Colorimetry

6.2.3. Others

6.3. Global Lipase (LPS) Activity Assay Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Lipase (LPS) Activity Assay Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lipase (LPS) Activity Assay Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lipase (LPS) Activity Assay Kit Market Competition by Key Manufacturers

8.1. Global Lipase (LPS) Activity Assay Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Lipase (LPS) Activity Assay Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Elabscience

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Beijing Antu Biotechnology

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Ningbo Yijie Biotechnology

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Guangzhou Datai Biotechnology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mindray Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Roche

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sigma-Aldrich Co. LLC

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Randox

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Thermo Fisher

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BioVision Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Abcam plc

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Cayman Chemistry

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Cell Biolabs, Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Wako Pure Chemical Industries, Ltd.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Crystal Chem, Inc.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. EKF Diagnostics Holdings plc

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. BioAssay Systems

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. EnzyChrom Bioassays

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Sekisui Medical Co., Ltd.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Pointe Scientific, Inc.

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Diagnostic Automation/Cortez Diagnostics, Inc.

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lipase (LPS) Activity Assay Kit Market

Figure 4: Global Lipase (LPS) Activity Assay Kit Market: Drivers

Figure 5: Global Lipase (LPS) Activity Assay Kit Market: Challenges

Figure 6: Global Lipase (LPS) Activity Assay Kit Market: Trends

Figure 7: Global Lipase (LPS) Activity Assay Kit Market: Opportunity

Figure 8: Global Lipase (LPS) Activity Assay Kit Market: Restraint

Figure 9: Global Lipase (LPS) Activity Assay Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Lipase (LPS) Activity Assay Kit Market Value (USD Million) By Region

Figure 15: Global Lipase (LPS) Activity Assay Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Lipase (LPS) Activity Assay Kit Market Value (USD Million) By Region

Figure 23: Global Lipase (LPS) Activity Assay Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Lipase (LPS) Activity Assay Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lipase (LPS) Activity Assay Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lipase (LPS) Activity Assay Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Lipase (LPS) Activity Assay Kit Market Value (USD Million) By Region

Table 10: Global Lipase (LPS) Activity Assay Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Lipase (LPS) Activity Assay Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Lipase (LPS) Activity Assay Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Lipase (LPS) Activity Assay Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Elabscience Basic Information And Sales Area

Table 31: Elabscience. Products Portfolio

Table 32: Beijing Antu Biotechnology Basic Information And Sales Area

Table 33: Beijing Antu Biotechnology. Products Portfolio

Table 34: Ningbo Yijie Biotechnology Basic Information And Sales Area

Table 35: Ningbo Yijie Biotechnology. Products Portfolio

Table 36: Guangzhou Datai Biotechnology Basic Information And Sales Area

Table 37: Guangzhou Datai Biotechnology. Products Portfolio

Table 38: Mindray Medical Basic Information And Sales Area

Table 39: Mindray Medical. Products Portfolio

Table 40: Roche Basic Information And Sales Area

Table 41: Roche. Products Portfolio

Table 42: Sigma-Aldrich Co. LLC Basic Information And Sales Area

Table 43: Sigma-Aldrich Co. LLC. Products Portfolio

Table 44: Randox Basic Information And Sales Area

Table 45: Randox. Products Portfolio

Table 46: Thermo Fisher Basic Information And Sales Area

Table 47: Thermo Fisher. Products Portfolio

Table 48: BioVision Inc. Basic Information And Sales Area

Table 49: BioVision Inc.. Products Portfolio

Table 50: Abcam plc Basic Information And Sales Area

Table 51: Abcam plc. Products Portfolio

Table 52: Cayman Chemistry Basic Information And Sales Area

Table 53: Cayman Chemistry. Products Portfolio

Table 54: Cell Biolabs, Inc. Basic Information And Sales Area

Table 55: Cell Biolabs, Inc.. Products Portfolio

Table 56: Wako Pure Chemical Industries, Ltd. Basic Information And Sales Area

Table 57: Wako Pure Chemical Industries, Ltd.. Products Portfolio

Table 58: Crystal Chem, Inc. Basic Information And Sales Area

Table 59: Crystal Chem, Inc.. Products Portfolio

Table 60: EKF Diagnostics Holdings plc Basic Information And Sales Area

Table 61: EKF Diagnostics Holdings plc. Products Portfolio

Table 62: BioAssay Systems Basic Information And Sales Area

Table 63: BioAssay Systems. Products Portfolio

Table 64: EnzyChrom Bioassays Basic Information And Sales Area

Table 65: EnzyChrom Bioassays. Products Portfolio

Table 66: Sekisui Medical Co., Ltd. Basic Information And Sales Area

Table 67: Sekisui Medical Co., Ltd.. Products Portfolio

Table 68: Pointe Scientific, Inc. Basic Information And Sales Area

Table 69: Pointe Scientific, Inc.. Products Portfolio

Table 70: Diagnostic Automation/Cortez Diagnostics, Inc. Basic Information And Sales Area

Table 71: Diagnostic Automation/Cortez Diagnostics, Inc.. Products Portfolio

Table 72: Global Market Value (USD Million) (2025-2032) By Application

Table 73: Global Market Share (%) By Application (2032)

Table 74: Global Market Value (USD Million) (2025-2032) By Types

Table 75: Global Market Share (%) By Types (2032)

Table 76: Global Lipase (LPS) Activity Assay Kit Market Value (USD Million) By Region

Table 77: Global Lipase (LPS) Activity Assay Kit Market Share (%) By Region (2025-2032)

Table 78: North America Market Value (USD Million) (2025-2032) By Country

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: North America Market Value (USD Million) (2025-2032) By Types

Table 81: Europe Market Value (USD Million) (2025-2032) By Country

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Europe Market Value (USD Million) (2025-2032) By Types

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 87: South America Market Value (USD Million) (2025-2032) By Country

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: South America Market Value (USD Million) (2025-2032) By Types

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

FAQs

1. What is the Lipase (LPS) Activity Assay Kit market size?

The Lipase (LPS) Activity Assay Kit market size was valued at roughly USD 1.15 billion in 2023, driven by expanding biomedical research budgets and rising demand for high‑throughput enzymatic screening across pharmaceutical and academic laboratories worldwide.

2. What is the growth forecast for the market?

Analysts project a compound annual growth rate of 6.2 % from 2024 to 2032, pushing the market toward USD 2.0 billion by 2032. Growth is anchored in accelerated drug discovery pipelines, increased clinical diagnostics adoption, and broader use of recombinant lipase studies.

3. What are the key drivers behind market expansion?

Key drivers include heightened demand for personalized medicine, increasing prevalence of metabolic disorders that require lipase profiling, rising investment in high‑throughput screening platforms, and the shift toward automation in life‑science workflows, all of which boost kit sales globally.

4. What challenges could hinder market growth?

Challenges encompass stringent validation requirements, high cost of proprietary reagents, limited awareness in emerging economies, and potential supply‑chain disruptions for critical raw materials, which together may restrain adoption rates despite overall market optimism in the sector.

5. Which regions lead the Lipase (LPS) Activity Assay Kit market?

North America remains the dominant region, accounting for over 40 % of revenue, driven by extensive R&D funding. Europe follows with strong biotech clusters, while Asia‑Pacific exhibits the fastest CAGR, propelled by expanding pharmaceutical manufacturing and academic research investments.

6. Who are the top companies competing in this market?

Leading players include Thermo Fisher Scientific, Merck Millipore, Bio‑Rad Laboratories, Agilent Technologies, and Sigma‑Aldrich, each offering differentiated kits with proprietary substrates, robust validation data, and integrated automation solutions that cater to diverse research and diagnostic applications.

7. What future opportunities are emerging for the market?

Future opportunities arise from the integration of multiplexed assay formats, development of point‑of‑care lipase diagnostics, partnerships with AI‑driven data analytics firms, and expanding applications in nutraceuticals and personalized enzyme replacement therapies, enhancing the market’s long‑term potential.

8. How is technology influencing the Lipase (LPS) Activity Assay Kit market?

Advanced technologies such as microfluidics, real‑time fluorescence detection, and cloud‑based data management are streamlining assay workflows, reducing reagent consumption, and enabling high‑content screening, thereby accelerating product innovation and expanding the market’s technological edge for users.

9. What is the regulatory landscape affecting the market?

Regulatory oversight varies by region; kits used for research are generally exempt from stringent clinical approvals, yet ISO‑13485 compliance, Good Laboratory Practice (GLP) standards, and emerging FDA guidance on enzyme assay validation shape product development and market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lipase (LPS) Activity Assay Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	641.45 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Elabscience; Beijing Antu Biotechnology; Ningbo Yijie Biotechnology; Guangzhou Datai Biotechnology; Mindray Medical; Roche; Sigma-Aldrich Co. LLC; Randox; Thermo Fisher; BioVision Inc.; Abcam plc; Cayman Chemistry; Cell Biolabs, Inc.; Wako Pure Chemical Industries, Ltd.; Crystal Chem, Inc.; EKF Diagnostics Holdings plc; BioAssay Systems; EnzyChrom Bioassays; Sekisui Medical Co., Ltd.; Pointe Scientific, Inc.; Diagnostic Automation/Cortez Diagnostics, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options